Venetoclax ex vivo functional profiling predicts improved progression-free survival.
Vilas A GuptaShannon M MatulisBenjamin G BarwickR Devin BogConrad W ShebelutMala ShanmugamPaola NeriNizar J BahlisMadhav V DhodapkarLeonard T HeffnerCraig C HofmeisterNisha S JosephSagar LonialJonathan L KaufmanDavid L JayeAjay K NookaLawrence H BoisePublished in: Blood cancer journal (2022)